Predicting the future from the past: volatile markers for respiratory infections

Alvar Agustí

Source: Eur Respir J, 49 (5) 1750264; 10.1183/13993003.50264-2017

Journal Issue: May

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Alvar Agustí. Predicting the future from the past: volatile markers for respiratory infections. Eur Respir J, 49 (5) 1750264; 10.1183/13993003.50264-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021
Are antimicrobials still the future of respiratory infection therapy? Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021
From the bedside: upcoming new clinical strategies: novel strategies to combat respiratory viral infections Source: International Congress 2017 – Scientific year in review Year: 2017
Paediatric respiratory disease: past, present and future Source: Eur Respir J 2010; 36: 225 Year: 2010
Detecting lung infections in breathprints: empty promise or next generation diagnosis of infections Source: Eur Respir J 2015; 45: 21-24 Year: 2015
Is an elaborate bronchial sepsis screen in investigating recurrent respiratory infections worthwhile? Source: Eur Respir J 2002; 20: Suppl. 38, 609s Year: 2002
Interactions between bacterial and viral infections during COPD exacerbations: implications for prevention strategies Source: International Congress 2019 – Scientific Year in review Year: 2019
Antibiotic resistance in respiratory infections: challenges and actions for the upcoming decade Source: Virtual Congress 2021 – Respiratory infections Year: 2021
Can procalcitonin testing reduce antibiotic prescribing for respiratory infections? Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006
Predicting the future from the past Source: Eur Respir J 2017; 49(1): 1601854; DOI: 10.1183/13993003.01854-2016 Year: 2017
Lower respiratory tract infections among elderly primary care patients: a clinical prediction rule Source: Eur Respir J 2003; 22: Suppl. 45, 408s Year: 2003
Lower respiratory tract infections: diagnosis and treatment in clinical practice Source: International Congress 2014 – Primary Care Programme "Management of COPD and other respiratory conditions in clinical practice" Year: 2014
Are there risk factors that may influence use of antibiotics in viral lower respiratory tract infections in children? Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring Year: 2008
Do childhood respiratory infections continue to influence adult respiratory morbidity? Source: Eur Respir J 2009; 33: 237-244 Year: 2009
Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators Source: Eur Respir J 2007; 30: 556-573 Year: 2007
Risk indices of nosocomial infections as operational tools of continuous quality improving in respiratory medicine Source: Eur Respir J 2005; 26: Suppl. 49, 187s Year: 2005
Respiratory care in different situations: an overview of the epidemiology of respiratory diseases and their (co)morbidity Source: Virtual Congress 2020 – Part II: From symptoms to diagnosis in primary care Year: 2020